COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals
Faksova K, Walsh D, Jiang Y, et al. · Vaccine 42(9):2200–2211 · 2024
- Participants / data
- About 99 million vaccinated individuals across data sites in 8 countries.
- Key finding
- Confirmed previously identified safety signals — including myocarditis and pericarditis after mRNA vaccines, and Guillain-Barré syndrome and cerebral venous sinus thrombosis after the ChAdOx1 vaccine — and highlighted other potential signals for further investigation.
- Limitations
- Observed-vs-expected comparisons depend on background rates; a signal is a prompt for investigation, not proof of causation.
